ArticleFrontiers in psychiatry2025
Application of cerebellar vermis theta-burst stimulation patterned repetitive transcranial magnetic stimulation in patients with chronic schizophrenia.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Target Interpretability and Functional Mapping of rTMS and Theta-Burst Stimulation of the Cerebellar Vermis and Midline Cerebellum: A Scoping Review.Cerebellum (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To observe the therapeutic effects of cerebellar vermis theta-burst stimulation (TBS)-patterned repetitive transcranial magnetic stimulation (rTMS) in patients with chronic schizophrenia (CSZ). Methods: A total of 114 CSZ patients admitted to the hospital from February 2024 to July 2025 were enrolled and randomly divided into two groups (n=57 each). Both groups received conventional antipsychotic treatment, while the interventional group additionally underwent cerebellar vermis TBS-patterned rTMS, and the control group received sham stimulation. The treatment lasted for 4 weeks. The Positive and Negative Syndrome Scale (PANSS) score, Personal and Social Performance Scale (PSP) score, electrophysiological indexes of brain, MATRICS Consensus Cognitive Battery (MCCB) test and adverse reactions were compared between the two groups. Results: Following the intervention, both groups exhibited significant reductions in negative symptoms, general symptoms, and total PANSS scores, with the intervention group demonstrating significantly lower scores than the control group ( Conclusion: Cerebellar vermis TBS-patterned rTMS can effectively stimulate neural activity in CSZ patients, alleviate negative and general symptoms, improve disease control, enhance cognitive and social functioning, and demonstrate high safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.